Trade Mark Journal No.2026/030 24 July 2026

WO0000001914489 (9,10,42)

Office of origin: Switzerland

Date of International Registration:19 December 2025
Date of designation in the UK: 19 December 2025
Image for mark 1914489_TIF myLoop

International priority date claimed: 8 July 2025 (Switzerland) (834213)
Class 9
Computer hardware, apparatus for the transmission, storage and processing of data, particularly for medical and medicinal use, as well as for diagnostic use; software, particularly calculation, analysis, display, reading and control software, particularly for medical, diagnostic, and medicinal purposes; software for databases and software for representation and analysis of values provided by medical instruments and equipment for insulin pump treatment; software for databases and software for managing data of patients using insulin pumps; remote controls for medical instruments and equipment for insulin pump treatment; all the aforesaid goods, with the exception of goods integrating software that includes program loops as well as coil-shaped goods and coils.
Class 10
Infusion and injection apparatus and instruments for administering medicines; automated insulin delivery systems and parts and accessories thereof; medical infusion pumps as well as their parts and accessories; insulin pumps; patch pumps; cannulae; infusion sets as well as their parts and accessories; infusion kits as well as their parts and accessories; subcutaneous infusion sets; subcutaneous infusion kits; infusion sets comprising a cannula, medical tubing and medical fluid connectors; infusion tubing; ampoules for medical use; tanks for filling, for pharmaceutical products, particularly those intended for use with infusion apparatus; containers for pharmaceutical products, particularly for use with infusion apparatus; diabetes monitoring apparatus; blood glucose level measuring apparatus; bags specially adapted for infusion apparatus; all the aforesaid goods, with the exception of coil-shaped goods and coils.
Class 42
Scientific and technological services, as well as research and design relating thereto; design and development of computer hardware and software; Software as a Service [SaaS] for transmission, storage and digital processing of medical data relating to insulin pump therapies as well as values provided by medical apparatus and instruments intended for insulin pump therapies; Software as a Service [SaaS] for displaying and analyzing values provided by medical apparatus and instruments intended for insulin pump therapies; Software as a Service [SaaS] for insulin pump data management; Software as a Service [SaaS] for providing software used for monitoring insulin pumps and operating insulin pumps; all the aforesaid services, with the exception of services in the field of program loops and coils.

mylife Diabetes Care AG

Representative: mylife Diabetes Care IP Abteilung, Lyssachstrasse 40, CH-3400 Burgdorf, SWITZERLAND